This site was designed for more recent browsers, but it is accessible to any browser or Internet
device.
To view the site correctly please update your browser.
Click here for a list of more recent browsers.

![]()
Check this page often to learn about events at Boys Town National Research Hospital, scientific studies underway in our laboratories, and advances in diagnosis and treatment in our clinics.
![]()
![]()
William J. Kimberling, Ph.D., Director of the Center for the Study and Treatment of Usher Syndrome, will be the keynote speaker at the annual Deafblind International World Conference. The conference will be held September 25-30, 2007 in
Dr. Kimberling will present on the emerging medical therapies for deaf/blindness, including the advanced studies on vitamin A and antioxidants, which may play a role in delaying blindness in inherited diseases and retinal implants, which are microchips implanted on the surface or just behind the retina to help restore vision.
“Perhaps the most significant benefit lies in the potential for gene therapy,” says Dr. Kimberling. “We can now sort out the different genes and look at how each one responds to each treatment.”
Gene replacement therapy basically is a procedure where missing genetic information is replaced with the correct information, in the form of the missing DNA.
![]() |
Usher Syndrome is a genetic disorder that is the major cause of deaf/blindness in the